Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA).Acta Crystallogr C. 1998 Feb 15; 54 (Pt 2):229-31.AC
Abstract
The crystal structure of 3,4-methylenedioxymethamphetamine [systematic name: N-methyl-1-[3,4-(methylenedioxy) phenyl]-2-aminopropane] hydrochloride, C11H15NO2.HCl, also known as 'ecstasy' or MDMA, has been determined by X-ray diffraction.
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Language
eng
PubMed ID
9540200
Citation
Morimoto, B H., et al. "Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA)." Acta Crystallographica. Section C, Crystal Structure Communications, vol. 54 (Pt 2), 1998, pp. 229-31.
Morimoto BH, Lovell S, Kahr B. Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA). Acta Crystallogr C. 1998;54 (Pt 2):229-31.
Morimoto, B. H., Lovell, S., & Kahr, B. (1998). Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA). Acta Crystallographica. Section C, Crystal Structure Communications, 54 (Pt 2), 229-31.
Morimoto BH, Lovell S, Kahr B. Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA). Acta Crystallogr C. 1998 Feb 15;54 (Pt 2):229-31. PubMed PMID: 9540200.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA).
AU - Morimoto,B H,
AU - Lovell,S,
AU - Kahr,B,
PY - 1998/4/16/pubmed
PY - 1998/4/16/medline
PY - 1998/4/16/entrez
SP - 229
EP - 31
JF - Acta crystallographica. Section C, Crystal structure communications
JO - Acta Crystallogr C
VL - 54 (Pt 2)
N2 - The crystal structure of 3,4-methylenedioxymethamphetamine [systematic name: N-methyl-1-[3,4-(methylenedioxy) phenyl]-2-aminopropane] hydrochloride, C11H15NO2.HCl, also known as 'ecstasy' or MDMA, has been determined by X-ray diffraction.
SN - 0108-2701
UR - https://www.unboundmedicine.com/medline/citation/9540200/Ecstasy:_3_4_methylenedioxymethamphetamine__MDMA__
L2 - https://medlineplus.gov/clubdrugs.html
DB - PRIME
DP - Unbound Medicine
ER -
